Health and Fitness Health and Fitness
Tue, February 26, 2013
[ Tue, Feb 26th 2013 ] - Market Wire
UMKR Announces New Officers
[ Tue, Feb 26th 2013 ] - Market Wire
MPC
[ Tue, Feb 26th 2013 ] - Market Wire
Code Name: Gebze

Dynavax to Present at the Cowen and Company 33rd Annual Healthcare Conference


Published on 2013-02-26 06:16:27 - Market Wire
  Print publication without navigation


February 26, 2013 09:00 ET

Dynavax to Present at the Cowen and Company 33rd Annual Healthcare Conference

BERKELEY, CA--(Marketwire - Feb 26, 2013) - Dynavax Technologies Corporation (NASDAQ: [ DVAX ]) announced today that it will present at the Cowen and Company 33rd Annual Healthcare Conference in Boston on Tuesday, March 5, 2013 at 8:40 a.m. Eastern Time (5:40 a.m. Pacific Time).

Dino Dina, M.D., Chief Executive Officer of Dynavax, will provide a company overview. To access the slide presentation, live webcast, and subsequent archived recording, please visit Dynavax's website at [ http://investors.dynavax.com/newsevents.cfm ].

About Dynavax

Dynavax, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. Dynavax's lead product candidate is HEPLISAV , a Phase 3 investigational adult hepatitis B vaccine. For more information visit [ www.dynavax.com ].